ChemPartner and Trianni Announce Partnering Agreement
SAN FRANCISCO, Aug. 2, 2016 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) and ChemPartner, a leading science-driven, technologically advanced, high-quality preclinical research partner, today announced an agreement designed to facilitate third-party access to The Trianni Technology Platform. “We are happy to welcome ChemPartner as a partner,” said Dr. Matthias Wabl, Ph.D., Chairman and CEO of TRIANNI. “Because […]
